Cardiogenic Shock: a Prospective National Registry to Get Insights in Patients' Profile, Management and Outcome

What this Trial Is About

Researchers are collecting detailed information on patients experiencing cardiogenic shock (CS), a severe type of acute heart failure, who are admitted to Intensive Coronary Care Units. The study aims to better understand the profile, management, outcomes, and progression of these patients over time. It addresses the need for improved clinical classification and research on the varied causes and presentations of CS, especially given its high short-term mortality and the importance of specialized care centers. This observational registry includes all patients with cardiogenic shock admitted to Intensive Coronary Care Units from January 2020 through December 2030. The study tracks multiple clinical factors including the cause of shock, clinical presentation, current treatments, use of mechanical support devices, and patient outcomes. There are no interventions or treatments assigned by the study as it is focused on data collection and analysis. Participants will be followed for up to 10 years to monitor their clinical course, re-hospitalizations, and other outcomes. Researchers will collect information on clinical characteristics, management approaches, and patient evolution during their stay and long-term follow-up. The study involves reviewing medical data over this period to provide insights into how cardiogenic shock patients are treated and how they fare over time.

Altshock-2 REGISTRY